FDA Approves First Medication for Obstructive Sleep Apnea
Today, the FDA approved the first medication for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, to be used in combination with a reduced-calorie diet and...
GLP-1 medications for sleep apnea: potential benefits - WebMD
The only GLP-1 medication that is FDA-approved to treat sleep apnea is Zepbound; it likely does this by lowering your weight. "If you are not overweight, medications like semaglutide and ...
GLP-1s for Sleep Apnea
Jul 11, 2025 · Which GLP-1 Is Approved for Sleep Apnea? “The FDA has approved Zepbound (tirzepatide) as the first and only [so far] prescription medication for adults with moderate to severe …
Zepbound approved by FDA as first sleep apnea medication
Jan 9, 2025 · Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with sleep apnea.
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the …
FDA’s First GLP-1 Approval for Sleep Apnea May Reduce Reliance on …
In December 2024, the U.S. Food and Drug Administration (FDA) approved tirzepatide (Zepbound) for the treatment of obstructive sleep apnea (OSA) in adults with obesity.
GLP-1 Medication for Sleep Apnea | How These Drugs Are Changing ...
Jan 26, 2026 · GLP-1 Medication for Sleep Apnea — In December 2024 the FDA approved tirzepatide (Zepbound) as the first GLP-1 receptor agonist specifically indicated for moderate-to-severe …
Does GLP-1 Approved for Sleep Apnea | FDA Approval - Healthoper
Oct 10, 2025 · Yes, a GLP-1 medication has received FDA approval for treating moderate-to-severe obstructive sleep apnea in adults with obesity. In December 2024, the U.S. Food and Drug …
The impact of GLP-1 agonists on sleep disorders: spotlight on sleep apnea
Oct 21, 2025 · This approval adds to the current array of therapeutic options and raises many issues regarding the future of treatment for OSA; in particular, the role of glucagon-like peptide-1 receptor …
GLP-1 For Sleep Apnea - Neurology Advisor
In late 2024, the FDA’s approval of Zepbound for the treatment of OSA marks the first time a GLP-1 receptor agonist has been cleared for use outside of weight management and diabetes...